Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sydney Stern

Showing results (21-30 of 26) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 26 results.
JCI Insight|May 17, 2022
Targeting CAR and Nrf2 improves cyclophosphamide bioactivation while reducing doxorubicin-induced cardiotoxicity in triple-negative breast cancer treatmentSydney Stern, Dongdong Liang, Linhao Li, et al.
Journal of Pharmaceutical Sciences|June 20, 2026
Evolving landscape of drug development for pediatric rare diseases-from successes to strategies for addressing unmet needsSydney Stern, Yifei Zhang, Michelle Pressly, et al.
Bone & Joint Open|April 2, 2026
Optimal clinical management of tenosynovial giant cell tumours: a UK perspective, Sydney Stern, Robert Ashford, et al.
Cancer Treatment Reviews|December 11, 2022
Best clinical management of tenosynovial giant cell tumour (TGCT): A consensus paper from the community of expertsSilvia Stacchiotti, Hans Roland Dürr, Inga-Marie Schaefer, et al.
The Bone & Joint Journal|June 9, 2026
A modified Delphi consensus on tenosynovial giant cell tumour and giant cell tumour of bone : a report from the Birmingham Orthopaedic Oncology Meeting (BOOM)Lee M Jeys, Eduardo Botello, Richard Boyle, et al.
Bone & Joint Open|May 31, 2026
Complications of PI to PIII hemipelvic resections for intermediate and malignant tumours : a systematic review and meta-analysisMaria A Smolle, Florian A Wenzl, Minna K Laitinen, et al.
Pageof 3

Showing results (21-30 of 26) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 26 results.
JCI Insight|May 17, 2022
Targeting CAR and Nrf2 improves cyclophosphamide bioactivation while reducing doxorubicin-induced cardiotoxicity in triple-negative breast cancer treatmentSydney Stern, Dongdong Liang, Linhao Li, et al.
Journal of Pharmaceutical Sciences|June 20, 2026
Evolving landscape of drug development for pediatric rare diseases-from successes to strategies for addressing unmet needsSydney Stern, Yifei Zhang, Michelle Pressly, et al.
Bone & Joint Open|April 2, 2026
Optimal clinical management of tenosynovial giant cell tumours: a UK perspective, Sydney Stern, Robert Ashford, et al.
Cancer Treatment Reviews|December 11, 2022
Best clinical management of tenosynovial giant cell tumour (TGCT): A consensus paper from the community of expertsSilvia Stacchiotti, Hans Roland Dürr, Inga-Marie Schaefer, et al.
The Bone & Joint Journal|June 9, 2026
A modified Delphi consensus on tenosynovial giant cell tumour and giant cell tumour of bone : a report from the Birmingham Orthopaedic Oncology Meeting (BOOM)Lee M Jeys, Eduardo Botello, Richard Boyle, et al.
Bone & Joint Open|May 31, 2026
Complications of PI to PIII hemipelvic resections for intermediate and malignant tumours : a systematic review and meta-analysisMaria A Smolle, Florian A Wenzl, Minna K Laitinen, et al.
Pageof 3